These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10931169)

  • 1. Autoimmune thrombocytopenia: a complication of fludarabine therapy in lymphoproliferative disorders.
    Leach M; Parsons RM; Reilly JT; Winfield DA
    Clin Lab Haematol; 2000 Jun; 22(3):175-8. PubMed ID: 10931169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune thrombocytopenia due to chronic lymphocytic leukemia treated with fludarabine.
    Wells T; Kovacs MJ
    Ann Pharmacother; 2003 May; 37(5):671-4. PubMed ID: 12708944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune thrombocytopenia associated with the first cycle of fludarabine therapy in the treatment of relapsed non-Hodgkin's lymphoma.
    Churn M; Clough V
    Clin Oncol (R Coll Radiol); 2001; 13(4):273-5. PubMed ID: 11554624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fludarabine induced autoimmune haemolytic anaemia in a patient with chronic lymphocytic leukaemia.
    Syed NN; Khurshid M
    J Pak Med Assoc; 2006 Jan; 56(1):44-5. PubMed ID: 16454137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fludarabine induced immune thrombocytopenia in a patient with CD5 positive B cell chronic lymphocytic leukemia.
    Usman M; Adil SN; Sajid R; Khurshid M
    J Pak Med Assoc; 2003 Oct; 53(10):496-7. PubMed ID: 14696895
    [No Abstract]   [Full Text] [Related]  

  • 6. Fludarabine-related hemolytic anemia in chronic lymphocytic leukemia and lymphoproliferative disorders.
    Taha HM; Narasihman P; Venkatesh L; Cawley M; Kaplan B
    Am J Hematol; 1998 Dec; 59(4):316. PubMed ID: 9840913
    [No Abstract]   [Full Text] [Related]  

  • 7. Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia.
    Myint H; Copplestone JA; Orchard J; Craig V; Curtis D; Prentice AG; Hamon MD; Oscier DG; Hamblin TJ
    Br J Haematol; 1995 Oct; 91(2):341-4. PubMed ID: 8547072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of autoimmune thrombocytopenia after treatment with fludarabine in a patient with chronic lymphocytic leukemia.
    Montillo M; Tedeschi A; Leoni P
    Leuk Lymphoma; 1994 Sep; 15(1-2):187-8. PubMed ID: 7858499
    [No Abstract]   [Full Text] [Related]  

  • 9. Idiopathic thrombocytopenic purpura and myasthenia gravis after fludarabine treatment for chronic lymphocytic leukemia.
    Fujimaki K; Takasaki H; Koharazawa H; Takabayashi M; Yamaji S; Baba Y; Kanamori H; Ishigatsubo Y
    Leuk Lymphoma; 2005 Jul; 46(7):1101-2. PubMed ID: 16019566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chronic lymphocytic leukemia.
    Tertian G; Cartron J; Bayle C; Rudent A; Lambert T; Tchernia G
    Hematol Cell Ther; 1996 Aug; 38(4):359-60. PubMed ID: 8891729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fludarabine and hemolytic anemia in chronic lymphocytic leukemia.
    Hamblin TJ; Orchard JA; Myint H; Oscier DG
    J Clin Oncol; 1998 Sep; 16(9):3209-10. PubMed ID: 9738600
    [No Abstract]   [Full Text] [Related]  

  • 12. Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia.
    Hegde UP; Wilson WH; White T; Cheson BD
    Blood; 2002 Sep; 100(6):2260-2. PubMed ID: 12200396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia.
    Cortes J; O'Brien S; Loscertales J; Kantarjian H; Giles F; Thomas D; Koller C; Keating M
    Cancer; 2001 Oct; 92(8):2016-22. PubMed ID: 11596014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia.
    Bastion Y; Coiffier B; Dumontet C; Espinouse D; Bryon PA
    Ann Oncol; 1992 Feb; 3(2):171-2. PubMed ID: 1606091
    [No Abstract]   [Full Text] [Related]  

  • 15. Progressive multifocal leukoencephalopathy after fludarabine therapy for low-grade lymphoproliferative disease.
    Vidarsson B; Mosher DF; Salamat MS; Isaksson HJ; Onundarson PT
    Am J Hematol; 2002 May; 70(1):51-4. PubMed ID: 11994982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.
    Tsiara S; Christou L; Konstantinidou P; Panteli A; Briasoulis E; Bourantas KL
    Am J Hematol; 1997 Apr; 54(4):342. PubMed ID: 9092698
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fludarabine in the treatment of chronic lymphocytic leukemia and other lymphoproliferative disorders].
    Pawelski S
    Acta Haematol Pol; 1995; 26(3):263-8. PubMed ID: 8525771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia.
    Byrd JC; Hertler AA; Weiss RB; Freiman J; Kweder SL; Diehl LF
    Ann Oncol; 1995 Mar; 6(3):300-1. PubMed ID: 7612497
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia.
    Field K; Slavin MA; Seymour JF
    Eur J Haematol; 2002 Jul; 69(1):54-7. PubMed ID: 12270063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evans syndrome complicating fludarabine treatment for advanced B-CLL.
    Shvidel L; Shtarlid M; Klepfish A; Sigler E; Berrebi A
    Br J Haematol; 1997 Dec; 99(3):706. PubMed ID: 9401088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.